SFA
GILD icon

Souders Financial Advisors’s Gilead Sciences GILD Stock Holding History

Souders Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$407K Sell
3,223
-740
-19% -$97.5K 0.04% 161
2026
Q1 		$552K Buy
3,963
+714
+22% +$100K 0.06% 135
2025
Q4 		$399K Buy
3,249
+269
+9% +$32.7K 0.05% 154
2025
Q3 		$331K Sell
2,980
-504
-14% -$57.3K 0.04% 169
2025
Q2 		$386K Buy
3,484
+771
+28% +$82.1K 0.05% 145
2025
Q1 		$304K Buy
+2,713
New +$280K 0.04% 155
2022
Q1 		– Sell
-39,151
Closed -$2.84M – 149
2021
Q4 		$2.84M Buy
39,151
+895
+2% +$61.6K 0.82% 42
2021
Q3 		$2.67M Buy
38,256
+567
+2% +$39.8K 0.86% 41
2021
Q2 		$2.6M Buy
37,689
+557
+2% +$37.2K 0.87% 40
2021
Q1 		$2.4M Sell
37,132
-4,844
-12% -$312K 0.94% 36
2020
Q4 		$2.45M Sell
41,976
-505
-1% -$30.5K 1.07% 29
2020
Q3 		$2.58M Buy
42,481
+21,835
+106% +$1.51M 1.22% 25
2020
Q2 		$1.59M Sell
20,646
-10,482
-34% -$803K 0.91% 39
2020
Q1 		$2.33M Buy
+31,128
New +$2.15M 2.05% 11

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Souders Financial Advisors's GILD Position: Q2 2026 in Review

Souders Financial Advisors reduced its Gilead Sciences (GILD) stake by 19% in Q2 2026, selling an estimated $97.5K and leaving 3,223 shares worth $407K. The position accounts for 0.04% of the portfolio, ranked #161.

Souders Financial Advisors first reported a position in GILD in Q1 2020 and has held it in 14 quarters since. The position peaked at $2.84M in Q4 2021. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Souders Financial Advisors held 3,223 shares of Gilead Sciences worth $407K as of Q2 2026.
  • Souders Financial Advisors sold 740 Gilead Sciences shares in Q2 2026, an estimated $97.5K.
  • Gilead Sciences made up 0.04% of Souders Financial Advisors's portfolio in Q2 2026, its #161 holding.
  • Souders Financial Advisors first reported a position in Gilead Sciences in Q1 2020 and has held it in 14 quarters since.
  • Souders Financial Advisors's Gilead Sciences position peaked at $2.84M in Q4 2021.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Souders Financial Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.